Oramed Pharmaceuticals (NSDQ:ORMP) said today that it won approval from the Israel Securities Authority to dual-list its common stock on the Tel Aviv Stock Exchange.
Stock in the Jerusalem-based company is slated to begin trading on the TASE on July 12 under the symbol ‘ORMP’.
Get the full story at our sister site, Drug Delivery Business News.
The post Oramed to dual-list on Tel Aviv exchange appeared first on MassDevice.
from MassDevice http://ift.tt/2tqJXQd
Cap comentari:
Publica un comentari a l'entrada